Advanced Enzyme Technologies Reports 20% Y-o-Y Revenue Growth in Q1 FY26

Advanced Enzyme Technologies Limited, a leading specialty biotech company, has announced its unaudited financial results for the first quarter ended June 2025. The company reported a 20% year-over-year increase in revenue, standing at INR 1,859 million. EBITDA margin stood at 30%, PBT margin increased to a certain percentage, and PAT margin stood at 22%. The total revenue from operations grew by 20% on a year-over-year basis and 11% on a quarter-over-quarter basis. The human nutrition segment increased by 21%, and the animal nutrition segment grew by 51%. Domestic sales accounted for 53% of revenue from operations during Q1 FY26.